These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30651003)

  • 1. FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice.
    Yakala GK; Cabrera-Fuentes HA; Crespo-Avilan GE; Rattanasopa C; Burlacu A; George BL; Anand K; Mayan DC; Corlianò M; Hernández-Reséndiz S; Wu Z; Schwerk AMK; Tan ALJ; Trigueros-Motos L; Chèvre R; Chua T; Kleemann R; Liehn EA; Hausenloy DJ; Ghosh S; Singaraja RR
    Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):387-401. PubMed ID: 30651003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic overexpression of the prodomain of furin lessens progression of atherosclerosis and reduces vascular remodeling in response to injury.
    Lei X; Basu D; Li Z; Zhang M; Rudic RD; Jiang XC; Jin W
    Atherosclerosis; 2014 Sep; 236(1):121-30. PubMed ID: 25026302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice.
    Bauer RC; Tohyama J; Cui J; Cheng L; Yang J; Zhang X; Ou K; Paschos GK; Zheng XL; Parmacek MS; Rader DJ; Reilly MP
    Circulation; 2015 Mar; 131(13):1202-1213. PubMed ID: 25712206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
    Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.
    Schwanekamp JA; Lorts A; Vagnozzi RJ; Vanhoutte D; Molkentin JD
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):60-8. PubMed ID: 26564821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
    Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
    J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
    Larmann J; Jurk K; Janssen H; Müller M; Herzog C; Lorenz A; Schmitz M; Nofer JR; Theilmeier G
    PLoS One; 2015; 10(8):e0131854. PubMed ID: 26313756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
    Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-21 deficiency attenuated atherogenesis and decreased macrophage infiltration by targeting Dusp-8.
    Gao L; Zeng H; Zhang T; Mao C; Wang Y; Han Z; Chen K; Zhang J; Fan Y; Gu J; Wang C
    Atherosclerosis; 2019 Dec; 291():78-86. PubMed ID: 31704554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
    Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
    Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
    Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proprotein convertase furin/PCSK3 and atherosclerosis: New insights and potential therapeutic targets.
    Ren K; Jiang T; Zheng XL; Zhao GJ
    Atherosclerosis; 2017 Jul; 262():163-170. PubMed ID: 28400053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.
    Wang M; Subramanian M; Abramowicz S; Murphy AJ; Gonen A; Witztum J; Welch C; Tabas I; Westerterp M; Tall AR
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):976-84. PubMed ID: 24651678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.
    Gray SP; Di Marco E; Kennedy K; Chew P; Okabe J; El-Osta A; Calkin AC; Biessen EA; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):295-307. PubMed ID: 26715682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.
    Cansby E; Magnusson E; Nuñez-Durán E; Amrutkar M; Pedrelli M; Parini P; Hoffmann J; Ståhlman M; Howell BW; Marschall HU; Borén J; Mahlapuu M
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1723-1737. PubMed ID: 29930001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting Integrin α5 Cytoplasmic Domain Signaling Reduces Atherosclerosis and Promotes Arteriogenesis.
    Budatha M; Zhang J; Zhuang ZW; Yun S; Dahlman JE; Anderson DG; Schwartz MA
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29382667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The macrophage C-type lectin receptor CLEC5A (MDL-1) expression is associated with early plaque progression and promotes macrophage survival.
    Xiong W; Wang H; Lu L; Xi R; Wang F; Gu G; Tao R
    J Transl Med; 2017 Nov; 15(1):234. PubMed ID: 29126450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.